Galmed Pharmaceuticals EOCN
NASDAQ EOCN
$3.49 +0.02 (+0.58%)
At close: Sep 30, 2026 · 4:00 PM EDT

Galmed Pharmaceuticals (EOCN) Other Non-Current Liabilities (2013 - 2026)

Updated

Galmed Pharmaceuticals' Other Non-Current Liabilities came in at $1.62 million for Q2 2026.

Analysis

Galmed Pharmaceuticals (EOCN) Other Non-Current Liabilities (2013 - 2026) Analysis & Trends

At the end of FY2016, Galmed Pharmaceuticals' Other Non-Current Liabilities was $267,000, up 50.8% from FY2015.

  • Other Non-Current Liabilities carries a three-year compound annual growth rate of -14.6% (FY2013 to FY2016).
  • Going back by year, Other Non-Current Liabilities was $177,000 in FY2015 and $428,000 in FY2013.
  • The Q2 2026 figure represents the lowest quarterly Other Non-Current Liabilities since Q2 2017.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn
10 Galmed Pharmaceuticals 406,071.97 406,071.97 -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 1.62 Mn
Jun 30, 2017 150,000.00
Dec 31, 2016 267,000.00
Jun 30, 2016 222,000.00
Dec 31, 2015 177,000.00
Dec 31, 2013 428,000.00
API Access

Galmed Pharmaceuticals Other Non-Current Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-non-current-liabilities&ticker=EOCN&period=max&api_key=YOUR_API_KEY